文献速递皮肤肿瘤

COVID-19大流行对荷兰角质形成细胞癌的影响:诊断趋势与诊断延迟程度

The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2022-02-09

本研究利用荷兰癌症登记处数据,比较2020年各月角质形成细胞癌(cSCC和BCC)实际诊断数与基于2017-2019年趋势外推的预期诊断数。2020年3月至5月cSCC和BCC诊断数分别较预期下降29%和50%,所有年龄组、性别和地区均可见下降;6月至9月诊断数高于预期,10月至12月略低于预期。2020年底仍积压约1150例cSCC和11767例BCC。

要点

  • 2020年3月至5月cSCC诊断数较预期下降29%,BCC下降50%,所有年龄组、性别和地区均可见下降。
  • 2020年6月至9月cSCC和BCC诊断数高于预期,10月至12月略低于预期。
  • 2020年底仍有约1150例cSCC和11767例BCC的诊断积压。

核心结论

  • COVID-19大流行期间角质形成细胞癌诊断不理想,诊断延迟可能源于患者和卫生系统两方面原因。
  • 需进一步研究以确定这些诊断延迟对结局的影响。

研究设计与样本

  • 研究使用荷兰癌症登记处数据,比较2020年各月cSCC和BCC实际诊断数与预期诊断数。
  • 预期诊断数通过外推2017-2019年观察到的趋势计算,以考虑角质形成细胞癌发病率的年度增长。
  • 比较进一步按年龄、性别和地区分层。
  • 估计诊断延迟并校正大流行超额死亡对角质形成细胞癌发病率的影响。

主要发现

  • 2020年3月至5月cSCC诊断数较预期下降29%,BCC下降50%。
  • 上述下降在所有年龄组、两性和所有地区均观察到。
  • 2020年6月至9月cSCC和BCC诊断数高于预期,10月至12月略低于预期。
  • 2020年底仍积压约1150例cSCC和11767例BCC。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The COVID-19 pandemic impacted Dutch society and the healthcare system. Focus switched to care for COVID-19 patients, thereby altering care for non-COVID patients. Non-urgent medical visits were cancelled or postponed and patients were reluctant to visit healthcare services. OBJECTIVES: This study aimed to investigate the impact of the COVID-19 pandemic on trends in diagnoses of keratinocyte carcinoma (cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC)) and to assess the magnitude of diagnostic delays. METHODS: The number of cSCC and BCC diagnoses in each month of 2020 was compared to the expected number of diagnoses for these months, using data from the Netherlands Cancer Registry. Expected diagnoses for 2020 were used as a reference to take the yearly increase in keratinocyte carcinoma incidence into account and were calculated by extrapolating the trends observed in 2017-2019. Comparisons were further stratified by age, sex and region. Estimates of diagnostic delays were calculated and corrected for the influence of excess mortality due to the pandemic on keratinocyte carcinoma incidence. RESULTS: The number of cSCC and BCC diagnoses substantially decreased when compared to the number of diagnoses expected from March to May 2020 (cSCC -29%, BCC -50%). These decreases were observed across all age groups, both sexes, and all regions. From June to September the number of cSCC and BCC diagnoses was higher than expected, after which it slightly dropped below expected in October to December. In total, 2020 keratinocyte carcinoma diagnoses continued to trail those expected, with a backlog of around 1150 cSCCs and 11 767 BCCs remaining at the end of the year. CONCLUSION: Diagnosis of keratinocyte carcinoma was suboptimal during the COVID-19 pandemic, due to diagnostic delays likely resulting from both patient and health system-related delay. Further studies will need to determine the effects of these diagnostic delays on outcomes.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Slotman E, Schreuder K, Nijsten TEC, et al. The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays. J Eur Acad Dermatol Venereol. 2022. PMID: 35092107. doi:10.1111/jdv.17976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。